Comparison of histidine-tryptophan ketoglutarate solution and University of Wisconsin solution in prolonged cold preservation of kidney allografts

Transplantation. 2006 Feb 15;81(3):480-2. doi: 10.1097/01.tp.0000196724.89757.79.

Abstract

Although University of Wisconsin (UW) solution is the standard preservation solution for organ transplantation, Histidine-Tryptophan Ketogluatarate (HTK) solution has been increasingly used. This study compared HTK or UW for cold static storage of kidney allografts. In all, 149 renal transplants were performed with cold ischemic times (CI) greater than 16 hr (UW 87, HTK 62) and a subset analysis was performed with CI over 24 hr (HTK 31, UW 38). Data from receiving renal transplant centers focused on delayed graft function (DGF), patient and allograft survival. In CI greater than 16 hr, graft and patient survival were comparable. HTK cohort had lower DGF. In CI greater than 24 hr, there was no difference in patient survival, a trend towards improved graft survival in HTK, and decreased rate of DGF in HTK. This data suggests that UW and HTK have at least similar efficacy in kidney preservation at longer ischemic times.

Publication types

  • Comparative Study
  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine
  • Adult
  • Allopurinol
  • Cold Ischemia*
  • Female
  • Glucose
  • Glutathione
  • Graft Survival
  • Humans
  • Insulin
  • Kidney Transplantation* / mortality
  • Kidney*
  • Living Donors
  • Male
  • Mannitol
  • Middle Aged
  • Organ Preservation Solutions*
  • Organ Preservation*
  • Potassium Chloride
  • Procaine
  • Raffinose

Substances

  • Bretschneider cardioplegic solution
  • Insulin
  • Organ Preservation Solutions
  • University of Wisconsin-lactobionate solution
  • Mannitol
  • Procaine
  • Allopurinol
  • Potassium Chloride
  • Glutathione
  • Glucose
  • Adenosine
  • Raffinose